What is Vyvanse?
Vyvanse is an amphetamine-based drug prescribed to treat attention-deficit hyperactivity disorder (ADHD). It is generically known as Lisdexamfetamine and was introduced in the U.S. in 1997 as a means to treat ADHD. It was originally developed as a more effective, but less potent alternative to other amphetamine-based ADHD drugs like Adderall and Ritalin. Unfortunately, many people end up needing a Vyvanse addiction treatment program.
Vyvanse is formulated with time-released properties to make its initial effects less instantaneous and more prolonged in its users. It releases small amounts of its active ingredients gradually over time, throughout the day. This feature is what made it more marketable as a better and more effective means to treat ADHD because rather than taking a medication multiple times a day (like with Adderall and Ritalin), patients could take one dose that lasts them throughout the day.
This time-released formulation can be tampered with by simply emptying out the Vyvanse capsules and snorting the drug, which many people with a Vyvanse addiction do.